Altimmune, Inc(NASDAQ:ALT) 
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing intranasal vaccines, immune modulating therapies, and treatments for liver disease. The company develops AdCOVID, a single-dose intranasal vaccine that is in Phase I clinical trial to protect against COVID-19; T-COVID...
Website: http://www.altimmune.com
Founded: 1997
Full Time Employees: 25
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2024-07-22
P
O 6.41
H 6.48
L 6.09
C 6.37
V 2,601,905
10EMA 6.37
20EMA 6.37
60EMA 6.37
120EMA 6.37
250EMA 6.37